Glenmede Trust CO Na Johnson & Johnson Transaction History

Glenmede Trust CO Na

$20.6 Billion
Q3 2024

A detailed history of Glenmede Trust CO Na transactions in Johnson & Johnson stock. As of the latest transaction made, Glenmede Trust CO Na holds 1,662,889 shares of JNJ stock, worth $242 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares

1,662,889

Previous 1,612,998 3.09%

Holding current value

$242 Million

Previous $236 Million 14.31%

% of portfolio

1.31%

Previous 1.21%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$145.48 - $167.38 $7.26 Million - $8.35 Million	49,891 Added 3.09%	1,662,889 $269 Million
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $4.83 Million - $5.27 Million	33,420 Added 2.12%	1,612,998 $236 Million
Q1 2024 May 15, 2024	SELL	$155.22 - $162.74 $11.3 Million - $11.8 Million	-72,690 Reduced 4.4%	1,579,578 $250 Million
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $1.36 Million - $1.49 Million	-9,361 Reduced 0.56%	1,652,268 $259 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $5.35 Million - $6 Million	-34,378 Reduced 2.03%	1,661,629 $259 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $3.05 Million - $3.64 Million	-20,217 Reduced 1.18%	1,696,007 $263 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $3.08 Million - $3.45 Million	-19,196 Reduced 1.11%	1,716,224 $303 Million
Q3 2022 Nov 16, 2022	BUY	$161.33 - $179.52 $676,940 - $753,265	4,196 Added 0.24%	1,735,420 $283 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $5.09 Million - $5.63 Million	-30,278 Reduced 1.72%	1,731,224 $307 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $23 Million - $26.2 Million	-145,733 Reduced 7.64%	1,761,502 $312 Million
Q4 2021 Feb 15, 2022	SELL	$155.93 - $173.01 $1.74 Million - $1.93 Million	-11,182 Reduced 0.58%	1,907,235 $326 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $30.1 Million - $33.5 Million	-186,667 Reduced 8.87%	1,918,417 $310 Million
Q2 2021 Aug 16, 2021	SELL	$159.48 - $171.07 $24.1 Million - $25.9 Million	-151,402 Reduced 6.71%	2,105,084 $347 Million
Q1 2021 May 18, 2021	BUY	$153.07 - $170.48 $27.3 Million - $30.4 Million	178,451 Added 8.59%	2,256,486 $371 Million
Q4 2020 Feb 16, 2021	BUY	$137.11 - $157.38 $17.1 Million - $19.6 Million	124,703 Added 6.38%	2,078,035 $327 Million
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $20.9 Million - $22.9 Million	148,594 Added 8.23%	1,953,332 $291 Million
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $6.76 Million - $8.16 Million	-52,464 Reduced 2.82%	1,804,738 $254 Million
Q4 2019 Feb 12, 2020	SELL	$127.5 - $146.44 $5.78 Million - $6.64 Million	-45,333 Reduced 2.38%	1,857,202 $271 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $14.5 Million - $16.2 Million	-113,864 Reduced 5.65%	1,902,535 $246 Million
Q2 2019 Aug 13, 2019	BUY	$131.15 - $144.24 $2.01 Million - $2.21 Million	15,355 Added 0.77%	2,016,399 $281 Million
Q1 2019 May 14, 2019	SELL	$125.72 - $139.79 $2.93 Million - $3.26 Million	-23,323 Reduced 1.15%	2,001,044 $280 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $1.55 Million - $1.87 Million	-12,617 Reduced 0.62%	2,024,367 $261 Million
Q3 2018 Nov 15, 2018	SELL	$121.58 - $142.88 $735 Million - $864 Million	-6,048,824 Reduced 74.81%	2,036,984 $281 Million
Q2 2018 Nov 05, 2018	SELL	$119.4 - $131.76 $1.68 Billion - $1.86 Billion	-14,088,874 Reduced 63.54%	8,085,808 $981 Million
Q2 2018 Aug 15, 2018	BUY	$119.4 - $131.76 $1.59 Billion - $1.75 Billion	13,295,992 Added 149.75%	22,174,682 $2.69 Billion
Q4 2017 Feb 15, 2018	SELL	$131.22 - $143.62 $18.6 Million - $20.4 Million	-142,119 Reduced 1.58%	8,878,690 $1.24 Billion
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $1.17 Billion - $1.22 Billion	9,020,809	9,020,809 $0

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $380B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.

Account

Glenmede Trust CO Na Johnson & Johnson Transaction History